Search results

Order by most recent / most popular / relevance

Results: 1-10 of 46

Legal - or what?

Torys LLP
-
Canada, USA
-
April 17 2012

"How can you manage issues arising from regulations and legal requirements in different jurisdictions."

Canada’s PAAB releases updated Code of Advertising Acceptance

Torys LLP
-
Canada
-
December 7 2012

The Pharmaceutical Advertising Advisory Board (PAAB) has released a revised version of its Code of Advertising Acceptance

Health Canada announces intent to develop a framework for orphan drug approval

Torys LLP
-
Canada, USA
-
October 5 2012

On October 3, 2012, Health Canada issued a press release announcing that it will develop a framework for the marketing approval of drugs to treat rare life-threatening, seriously debilitating or serious chronic rare diseases that are commonly referred to as "orphan drugs."

Data protection in Canada: Court of Appeal confirms narrow approach

Torys LLP
-
Canada
-
January 30 2013

On January 18, 2013, the Federal Court of Appeal (FCA) released its decision in Takeda Canada Inc. v. The Minister of Health and Attorney General of

More biopharma M&A in 2010, but healthy or distressed?

Torys LLP
-
Canada
-
December 31 2009

As blockbuster drugs began to come off patent, big pharmas fearing loss of revenue share rushed to couple with their counterparts in 2009

Court affirms Health Canada’s broad discretion in review of drug submissions

Torys LLP
-
Canada
-
April 13 2010

In a recent decision of the Federal Court in Hospira Healthcare Corporation v. Canada (Attorney General) the Court affirmed that Health Canada has broad discretion in interpreting the Food and Drug Regulations to determine the content of an application for the marketing approval of a drug

Canadian privacy commissioners release guidance on workplace H1N1 privacy

Torys LLP
-
Canada
-
November 18 2009

On October 29, 2009 the Office of the Privacy Commissioner of Canada (OPC), together with the Privacy Commissioners’ offices of Alberta and British Columbia, published a guidance document titled "Privacy in the Time of a Pandemic: Guidance for Organizations."

Promotion of drugs and devices at international conferences held in Canada

Torys LLP
-
Canada
-
February 3 2009

As a neighbor, Canada is often selected as a venue for international conferences of U.S. drug and device manufacturers

Canada’s Federal Court of Appeal limits damages available to delayed generics

Torys LLP
-
Canada
-
June 8 2009

On June 4, 2009, in Merck Frosst Canada Inc. v. Apotex, Inc., the Federal Court of Appeal released an important decision limiting the range of damages available in actions under section 8 of the Patented Medicines (Notice of Compliance) Regulations